生物分析测试服务市场规模、份额及成长分析（按分子、测试、工作流程、应用、最终用途和地区）－2025 年至 2032 年产业预测

2023 年生物分析测试服务市场规模价值 36 亿美元，预计将从 2024 年的 41.8 亿美元成长到 2032 年的 139 亿美元，预测期间（2025-2032 年）的复合年增长率为 16.2%。

全球生物分析测试服务市场包括向製药、生物製药和生物技术产业提供的分析服务，以支援药物开发和研究。这些服务涉及分析血液、尿液和组织等生物样本，以测量药物浓度、代谢物和生物标记物，从而评估药物安全性、有效性和药物动力学。委外研发机构（CRO）和专业服务供应商在提供这些重要服务方面发挥着至关重要的作用。生物分析测试服务市场的主要目标是提供可靠、准确的测试，以促进安全有效的药物进入市场。然而，一些挑战阻碍了市场成长。特别是生物分析测试服务的高成本令人望而却步，特别是对于较小的製药公司和研究机构。此外，生物分析测试固有的复杂性和技术挑战可能会限制结果的效率和准确性，从而延长週转时间并可能为资料解释带来问题。另一个主要问题是分析方法和程序缺乏标准化。方法上的差异会导致资料不一致，并使不同研究和实验室之间的结果比较和检验变得复杂。这种缺乏统一性可能会阻碍药物开发过程并延迟监管部门的核准。应对这些挑战需要共同努力，标准化分析方法，投资先进技术以简化流程，并实施具有成本效益的策略。这些措施对于克服现有障碍和推动生物分析测试服务市场的成长至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

生物分析测试服务市场规模（按分子和复合年增长率）（2025-2032）

• 市场概览
• 小分子
• 大分子
  • 液相层析质谱研究
  • 免疫检测
  • PK
  • ADA
  • 其他的
• 其他的

生物分析测试服务市场规模（按测试类型和复合年增长率）（2025-2032）

• 市场概览
• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• 生物利用度
• 生物等效性
• 其他的

生物分析测试服务市场规模（依工作流程及复合年增长率）（2025-2032）

• 市场概览
• 样品製备
  • 蛋白质沉淀
  • 液-液萃取
  • 固相萃取
• 样品分析
  • 联用技术
  • 层析法技术
  • 电泳
  • 配体结合试验
  • 质谱法
  • 核磁共振
• 其他工作流程

生物分析测试服务市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概览
• 肿瘤学
• 神经病学
• 感染疾病
• 胃肠病学
• 心臟病学
• 其他用途

生物分析测试服务市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概览
• 製药和生物製药公司
• CDMO
• CRO

生物分析测试服务市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Charles River Laboratories（USA）
• Labcorp Drug Development（USA）
• Eurofins Scientific（Luxembourg）
• SGS SA（Switzerland）
• PPD, Inc.
• ICON plc（Ireland）
• Syneos Health（USA）
• Q2 Solutions（USA）
• Intertek Group plc（UK）
• Parexel International Corporation（USA）
• ACM Global Laboratories（USA）
• Frontage Laboratories, Inc.（USA）
• BioAgilytix（USA）
• KCAS Bioanalysis & Biomarker Services（USA）
• Pacific BioLabs（USA）

结论和建议

Bioanalytical Testing Services Market size was valued at USD 3.6 Billion in 2023 and is poised to grow from USD 4.18 Billion in 2024 to USD 13.9 Billion by 2032, growing at a CAGR of 16.2% during the forecast period (2025-2032).

The global bioanalytical testing services market encompasses analytical services provided to pharmaceutical, biopharmaceutical, and biotechnology industries to support drug development and research. These services involve analyzing biological samples-such as blood, urine, and tissues-to determine drug concentrations, metabolites, and biomarkers, thereby assessing drug safety, efficacy, and pharmacokinetics. Contract research organizations (CROs) and specialized service providers play a pivotal role in delivering these essential services. A primary objective of the bioanalytical testing services market is to furnish reliable and accurate testing to facilitate the introduction of safe and effective drugs into the market. However, several challenges impede market growth. Notably, the high costs associated with bioanalytical testing services can be prohibitive, particularly for smaller pharmaceutical companies and research institutions. Additionally, the complexity and technical difficulties inherent in bioanalytical testing can limit the efficiency and accuracy of results, leading to extended turnaround times and potential data interpretation issues. Moreover, the lack of standardization in analytical methods and procedures poses significant challenges. Variations in methodologies can lead to inconsistencies in data, complicating the comparison and validation of results across different studies and laboratories. This lack of uniformity can hinder the drug development process and delay regulatory approvals. Addressing these challenges necessitates concerted efforts to standardize analytical methods, invest in advanced technologies to streamline processes, and implement cost-effective strategies. Such measures are vital to overcoming existing barriers and fostering growth within the bioanalytical testing services market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioanalytical Testing Services Market Segments Analysis

Global Bioanalytical Testing Services Market is segmented by Molecule, Test, Workflow, Application, End Use and region. Based on Molecule, the market is segmented into Small Molecule, Large Molecule and Others. Based on Test, the market is segmented into ADME, PK, PD, Bioavailability, Bioequivalence and Others. Based on Workflow, the market is segmented into Sample Preparation, Sample Analysis and Other Workflow Processes. Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology and Other Applications. Based on End Use, the market is segmented into Pharma & BioPharma Companies, CDMO and CRO. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioanalytical Testing Services Market

The escalating number of pharmaceutical trials and the intensified focus on developing new drugs and biopharmaceuticals are significantly boosting the demand for bioanalytical testing services. These services are crucial for ensuring the accuracy and reliability of data, which in turn guarantees the efficacy and safety of pharmaceutical products. As pharmaceutical companies invest more in research and development, there is a corresponding increase in the need for comprehensive bioanalytical testing to support drug development and regulatory approval processes.

Restraints in the Bioanalytical Testing Services Market

The substantial expenses associated with bioanalytical testing, particularly for advanced specialized analyses, can pose significant challenges for smaller pharmaceutical companies and research institutions. These high costs often serve as barriers, potentially hindering the progression of drug development projects within these organizations.

Market Trends of the Bioanalytical Testing Services Market

The integration of biomarker discovery into bioanalytical testing projects is gaining momentum, reflecting its critical role in personalized medicine, early diagnosis, and targeted therapies. Biomarkers-biological molecules measurable in blood, tissues, or other fluids-provide insights into normal or pathological processes and treatment responses. Their identification and validation are essential for diagnosing diseases, predicting outcomes, and tailoring treatments. Advanced technologies, such as mass spectrometry, genomics, and proteomics, facilitate the precise detection and quantification of these biomarkers. By leveraging these cutting-edge tools, bioanalytical testing services enhance the development of novel treatments and diagnostic tools, thereby advancing precision medicine and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Bioanalytical Testing Services Market Size by Molecule & CAGR (2025-2032)

• Market Overview
• Small Molecule
• Large Molecule
  • LC-MS Studies
  • Immunoassays
  • PK
  • ADA
  • Others
• Others

Global Bioanalytical Testing Services Market Size by Test & CAGR (2025-2032)

• Market Overview
• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• Bioavailability
• Bioequivalence
• Others

Global Bioanalytical Testing Services Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sample Preparation
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
• Sample Analysis
  • Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
• Other Workflow Processes

Global Bioanalytical Testing Services Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Applications

Global Bioanalytical Testing Services Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharma & BioPharma Companies
• CDMO
• CRO

Global Bioanalytical Testing Services Market Size & CAGR (2025-2032)

• North America (Molecule, Test, Workflow, Application, End Use)
  • US
  • Canada
• Europe (Molecule, Test, Workflow, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Molecule, Test, Workflow, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Molecule, Test, Workflow, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Molecule, Test, Workflow, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Q2 Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgilytix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCAS Bioanalysis & Biomarker Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific BioLabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations